Health, Longevity & Biohacking
Peter Attia says BPC-157 has patents despite “natural peptides” argument
Peter Attia Drive
403 ‒ Peptides: separating scientific promise from marketing hype
What was said
"Even BPC 157 has patents on all its salts and production methods. The pharmaceutical industry is many things, but indifferent to money is not one of them."
Peter Attia argues claims that pharmaceutical firms avoid peptides because “natural” molecules cannot be patented are only partly true. He says companies can patent modifications, delivery systems, manufacturing processes and dosing regimens, and adds BPC-157 has patents covering salts and production methods.
Verification status
Attributed speaker claim
Egleze verified who said this and where. The underlying claim has not been independently established by Egleze.
Source and context
Egleze verified who said this and where. The underlying claim has not been independently established by Egleze.
- Programme
- Peter Attia Drive
- Episode
- 403 ‒ Peptides: separating scientific promise from marketing hype
- Clip time
- 42:00
- Original source
- Watch the source segment →
From this episode
Peter Attia Drive